Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression
Summary Lung cancer in East Asia is characterized by a high percentage of never-smokers,
early onset and predominant EGFR mutations. To illuminate the molecular phenotype of this …
early onset and predominant EGFR mutations. To illuminate the molecular phenotype of this …
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Molecular glue compounds induce protein–protein interactions that, in the context of a
ubiquitin ligase, lead to protein degradation. Unlike traditional enzyme inhibitors, these …
ubiquitin ligase, lead to protein degradation. Unlike traditional enzyme inhibitors, these …
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma
Gene expression is regulated by promoters and enhancers marked by histone H3 lysine 27
acetylation (H3K27ac), which is established by the paralogous histone acetyltransferases …
acetylation (H3K27ac), which is established by the paralogous histone acetyltransferases …
Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns
M Salvadores, F Fuster-Tormo, F Supek - Science Advances, 2020 - science.org
Cell lines are commonly used as cancer models. The tissue of origin provides context for
understanding biological mechanisms and predicting therapy response. We therefore …
understanding biological mechanisms and predicting therapy response. We therefore …
Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in …
M Zhou, S Lv, Y Hou, R Zhang, W Wang, Z Yan… - Frontiers in …, 2022 - frontiersin.org
Aberrant sialylation plays a key biological role in tumorigenesis and metastasis, including
tumor cell survival and invasion, immune evasion, angiogenesis, and resistance to therapy …
tumor cell survival and invasion, immune evasion, angiogenesis, and resistance to therapy …
Evaluation of community pharmacists' perceptions and willingness to integrate ChatGPT into their pharmacy practice: a study from Jordan
Objectives This study aimed to examine the extent of community pharmacists' awareness of
Chat Generative Pretraining Transformer (ChatGPT), their willingness to embark on this new …
Chat Generative Pretraining Transformer (ChatGPT), their willingness to embark on this new …
A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer
M Shreberk-Shaked, B Dassa, S Sinha, S Di Agostino… - Cancer research, 2020 - AACR
Lung cancer is the leading cause of cancer-related deaths worldwide. The paralogous
transcriptional cofactors Yes-associated protein (YAP) and transcriptional coactivator with …
transcriptional cofactors Yes-associated protein (YAP) and transcriptional coactivator with …
WEE1 dependency and pejorative prognostic value in triple‐negative breast cancer
A de Nonneville, P Finetti, D Birnbaum… - Advanced …, 2021 - Wiley Online Library
In their recent paper,[1] Lamballe et al. identify the combination treatment with BCL-XL and
WEE1 inhibitors as a promising therapeutic approach in triple-negative breast cancer …
WEE1 inhibitors as a promising therapeutic approach in triple-negative breast cancer …
[HTML][HTML] Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi …
B Shi, J Ding, J Qi, Z Gu - International journal of medical sciences, 2021 - ncbi.nlm.nih.gov
Background: Large-scale loss-of-function screening database such as Cancer Dependency
Map (Depmap) provide abundant resources. Investigation of these potential dependency …
Map (Depmap) provide abundant resources. Investigation of these potential dependency …
[HTML][HTML] Molecular and pharmacological bladder cancer therapy screening: discovery of clofarabine as a highly active compound
IE Ertl, U Lemberger, D Ilijazi, MR Hassler… - European Urology, 2022 - Elsevier
Background The heterogeneity of bladder cancers (BCs) is a major challenge for the
development of novel therapies. However, given the high rates of recurrence and/or …
development of novel therapies. However, given the high rates of recurrence and/or …